These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 8437427)

  • 21. [Exogenous re-infection in tuberculosis].
    Tsuchiya T
    Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluations of MTD and Amplicor Mycobacterium for direct detection of Mycobacteria from clinical specimens].
    Sato A; Sonobe T; Okazaki M; Umeda B
    Kekkaku; 1999 May; 74(5):433-9. PubMed ID: 10386032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostic usefulness of the tuberculin reaction by PPD-B in Mycobacterium avium complex disease].
    Harada Y; Harada S; Kajiki A; Kitahara Y; Takamoto M; Ishibashi T
    Kekkaku; 1998 May; 73(5):349-53. PubMed ID: 9637819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare among patients without AIDS.
    Han XY; Tarrand JJ; Infante R; Jacobson KL; Truong M
    J Clin Microbiol; 2005 Sep; 43(9):4407-12. PubMed ID: 16145084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Mycobacterium avium complex isolated in eastern and central Japan by using DNA probes.
    Watanabe A; Kikuchi H; Shoji S; Nukiwa T; Motomiya M; Yoshida T; Takizawa S; Oizumi K
    Tohoku J Exp Med; 1995 Feb; 175(2):139-42. PubMed ID: 7597695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Present status of pulmonary atypical mycobacteriosis in community general hospitals].
    Yoshino K; Kusajima K; Ohishi F; Shimoide H; Murata Y; Sato N
    Kekkaku; 1989 Dec; 64(12):747-52. PubMed ID: 2615129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Case of pulmonary mycobacterium avium complex disease, showing hypersensitivity pneumonitis-like diffuse shadow].
    Ohashi R; Akagawa S; Kurashima A; Tsuchiya K; Miyamoto M; Masuda K; Tamura A; Nagai H; Nagayama N; Kawabe Y; Machida K; Yotsumoto H; Hebisawa A
    Kekkaku; 2006 Jan; 81(1):19-23. PubMed ID: 16479997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Skin reaction test using PPD-B].
    Tasaka H
    Kekkaku; 1993 Jan; 68(1):47-50. PubMed ID: 8437423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
    Ye JJ; Wu TS; Chiang PC; Lee MH
    J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ratio of number of patients with lung disease due to Mycobacterium avium-M. intracellulare complex against number of patients who showed culture-positive sputum specimens (author's transl)].
    Tsukamura M; Toyama H; Fukaya Y; Aoki M
    Kekkaku; 1982 Jan; 57(1):9-14. PubMed ID: 7069974
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of Mycobacterium avium and Mycobacterium intracellulare isolated in Puerto Rico from clinical samples by the use of a non-radioactive DNA probe.
    García MT; Peña I; Zlotnik H
    P R Health Sci J; 1994 Jun; 13(2):129-32. PubMed ID: 7938399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The epidemiology of pulmonary disease caused by Mycobacterium avium complex in Japan].
    Sakatani M
    Kekkaku; 1993 Jan; 68(1):43-6. PubMed ID: 8437422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
    J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clinical comparison between Mycobacterium avium and Mycobacterium intracellulare infections.
    Maesaki S; Kohno S; Koga H; Miyazaki Y; Kaku M
    Chest; 1993 Nov; 104(5):1408-11. PubMed ID: 8222796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The indication of surgical management in patients with pulmonary disease caused by Mycobacterium avium-intracellulare complex].
    Maekura R
    Kekkaku; 1997 Jan; 72(1):53-6. PubMed ID: 9038017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China.
    Zhang Z; Pang Y; Wang Y; Cohen C; Zhao Y; Liu C
    Int J Antimicrob Agents; 2015 May; 45(5):491-5. PubMed ID: 25795316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Purified protein derivatives prepared from Mycobacterium tuberculosis (PPDs) and M. intracellulare (PPD-B) in differential diagnosis of mycobacteriosis].
    Shigeto E
    Kekkaku; 1990 Nov; 65(11):701-9. PubMed ID: 2126050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difference in drug susceptibility distribution and clinical characteristics between
    Wang W; Yang J; Wu X; Wan B; Wang H; Yu F; Guo Y
    J Med Microbiol; 2021 May; 70(5):. PubMed ID: 33999797
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Huang CC; Wu MF; Chen HC; Huang WC
    J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Environmental risk factors for infection with Mycobacterium avium complex.
    Reed C; von Reyn CF; Chamblee S; Ellerbrock TV; Johnson JW; Marsh BJ; Johnson LS; Trenschel RJ; Horsburgh CR
    Am J Epidemiol; 2006 Jul; 164(1):32-40. PubMed ID: 16675537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.